JFS Wealth Advisors, LLC
- SEC CIK
- 0001568068
- Latest filing
- Jul 10, 2026
IBRX holding history
ImmunityBio, Inc. in every 13F filed by JFS Wealth Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IBRX overviewAll 13F holders of IBRXFull Q2 2026 holdings
- Shares (Q2 2026)
- 158
- Value
- $1.38K
- % of portfolio
- <0.1%
- Quarters held
- 11
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 158 | $1.38K | <0.1% | +158 | New | Holders |
| Q1 2026 | 0 | $0 | 0.0% | −213−100.0% | Sold out | Holders |
| Q4 2025 | 213 | $422 | <0.1% | +213 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −11−100.0% | Sold out | Holders |
| Q2 2025 | 11 | $30 | <0.1% | −31−73.8% | Reduced | Holders |
| Q1 2025 | 42 | $127 | <0.1% | −150−78.1% | Reduced | Holders |
| Q4 2024 | 192 | $492 | <0.1% | +176+1,100.0% | Added | Holders |
| Q3 2024 | 16 | $60 | <0.1% | −103−86.6% | Reduced | Holders |
| Q2 2024 | 119 | $753 | <0.1% | +109+1,090.0% | Added | Holders |
| Q1 2024 | 10 | $54 | <0.1% | +10 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −15−100.0% | Sold out | Holders |
| Q4 2022 | 15 | $76 | <0.1% | +15 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −19−100.0% | Sold out | Holders |
| Q1 2022 | 19 | $0 | 0.0% | +12+171.4% | Added | Holders |
| Q4 2021 | 7 | $0 | 0.0% | +7 | New | Holders |